Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACTIC study: CNS drug thresholds for cognitive improvement
jRCTs031240602Recruiting
- Sponsor
- Japan Anti-Doping Agency
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Pseudoephedrine cohort with Modafinil cohort (2 cohorts). Primary endpoint: DAT binding capacity in specific brain regions. Started Jan 2025; status: recruiting.
02
Drugs
pseudoephedrinemodafinil
Beyond the preview
Go deeper on jRCTs031240602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240602.